CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Open-market sale Chief Financial Officer sold 9,869 shares at $48.26 ($476,278)
- 4 Open-market sale General Counsel and Secretary sold 3,450 shares at $48.26 ($166,497)
- 4 Open-market sale Chief Executive Officer sold 10,349 shares at $48.26 ($499,443)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Open-market sale General Counsel and Secretary sold 2,800 shares at $52.80 ($147,840)
- 4 Open-market sale Chief Executive Officer sold 9,798 shares at $52.80 ($517,334)
- 8-K Event Other events
- 4 Open-market sale Chief Executive Officer sold 6,967 shares at $52.58 ($366,325)
- 4 Open-market sale General Counsel and Secretary sold 2,112 shares at $52.58 ($111,049)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Chief Medical Officer bought 1,508 shares at $32.96 ($49,704)
- 4 Planned sale Chief Financial Officer sold 34,972 shares at $60.19 ($2,104,965)
- 4 Planned sale Chief Executive Officer sold 90,000 shares at an average $57.40 ($5,166,298)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Other events
Page 4 of 45 · 883 filings